» Articles » PMID: 30551350

Dysregulation of Key MicroRNAs in Pancreatic Cancer Development

Overview
Date 2018 Dec 16
PMID 30551350
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Pancreatic cancer (PC) is mentioned as one of the fourth major cause of cancer-related deaths and also is considered as one of the most malignancies worldwide. Sadly, widely metastasis is frequently observed at the time of PC detection and there are, thereby, almost poor prognosis and ineffective treatment in PC patients. microRNAs (miRNAs), a group of short non-coding RNAs, regulate various cellular and developmental mechanisms, such as cell growth, proliferation, apoptosis, differentiation and angiogenesis. Also, they have essential roles even on the progression of different human and animal diseases. In recent years, extensive studies confirmed the important role of miRNAs in various steps of PC developments, including; tumor initiation, invasion and metastasis, which can use valuably for cancer detection, prognosis and therapy. Therefore, the present study reviewed the new recent investigations in miRNAs involvement in the biology of PC associated with their clinical implications.

Citing Articles

MicroRNAs in pancreatic cancer drug resistance: mechanisms and therapeutic potential.

Dong F, Zhou J, Wu Y, Gao Z, Li W, Song Z Front Cell Dev Biol. 2025; 12:1499111.

PMID: 39882259 PMC: 11774998. DOI: 10.3389/fcell.2024.1499111.


Targeting Triple NK Cell Suppression Mechanisms: A Comprehensive Review of Biomarkers in Pancreatic Cancer Therapy.

Fanijavadi S, Thomassen M, Jensen L Int J Mol Sci. 2025; 26(2).

PMID: 39859231 PMC: 11765000. DOI: 10.3390/ijms26020515.


MicroRNA-155 and its exosomal form: Small pieces in the gastrointestinal cancers puzzle.

Guo J, Zhong L, Momeni M Cell Biol Toxicol. 2024; 40(1):77.

PMID: 39283408 PMC: 11405467. DOI: 10.1007/s10565-024-09920-2.


Using microRNAs Networks to Understand Pancreatic Cancer-A Literature Review.

Przybyszewski O, Mik M, Nowicki M, Kusinski M, Mikolajczyk-Solinska M, Sliwinska A Biomedicines. 2024; 12(8).

PMID: 39200178 PMC: 11351910. DOI: 10.3390/biomedicines12081713.


The impact of COVID-19 on microRNA and CD marker expression in AML patients.

Saeed R, Abdulrahman Z, Mohammad D Sci Rep. 2024; 14(1):14251.

PMID: 38902412 PMC: 11190249. DOI: 10.1038/s41598-024-64775-1.